US Stock MarketDetailed Quotes
AYTU Aytu BioPharma
- 3.2100
- +0.1100+3.55%
Close May 9 16:00 ET
- 3.2300
- +0.0200+0.62%
Post 18:40 ET
17.87MMarket Cap-800P/E (TTM)
3.2100High3.0700Low9.49KVolume3.0700Open3.1000Pre Close29.98KTurnover0.25%Turnover RatioLossP/E (Static)5.57MShares3.500052wk High0.54P/B12.19MFloat Cap1.380052wk Low--Dividend TTM3.80MShs Float27279.9864Historical High--Div YieldTTM4.52%Amplitude1.3800Historical Low3.1600Avg Price1Lot Size
Aytu BioPharma Key Stats
Quarterly+Annual
YOY
| (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 94.47%-135K | 97.69%-211K | 82.21%-5.13M | 232.01%9.37M | 68.12%-2.91M | 72.34%-2.44M | -141.31%-9.15M | -11.01%-28.82M | -13.03%-7.1M | -3.82%-9.12M |
| Net income from continuing operations | 96.71%-220K | -1,058.35%-8.12M | 84.33%-17.05M | 84.73%-2.46M | 86.49%-7.2M | 42.04%-6.69M | 97.48%-701K | -86.62%-108.78M | 15.31%-16.09M | -109.31%-53.29M |
| Operating gains losses | 141.13%577K | 369.60%5.91M | -1,184.99%-4.79M | 1,090.21%1.42M | -1,352.78%-2.62M | ---1.4M | ---2.19M | -123.77%-373K | -111.93%-143K | ---180K |
| Depreciation and amortization | -1.22%2.18M | -3.09%2.23M | -13.12%8.82M | -4.68%2.12M | -14.84%2.19M | -17.53%2.21M | -14.05%2.3M | 10.27%10.15M | -33.19%2.22M | 30.46%2.57M |
| Other non cash items | -55.10%110K | -46.82%142K | 78.11%-404K | 56.18%-326K | 50.25%-590K | 181.61%245K | 9,000.00%267K | 58.66%-1.85M | 89.74%-744K | -157.27%-1.19M |
| Change In working capital | -49.59%-3.68M | 86.60%-1.35M | 46.63%-5.8M | 139.58%2.46M | 222.48%4.29M | -80.90%-2.46M | -4,878.67%-10.08M | -746.22%-10.86M | -221.57%-6.21M | -256.85%-3.5M |
| -Change in receivables | -79.86%479K | 84.79%-945K | -209.49%-7.15M | -11.96%5.18M | -87.29%-8.5M | 277.60%2.38M | -195.20%-6.21M | 323.12%6.53M | 2,775.45%5.89M | -221.46%-4.54M |
| -Change in inventory | -48.10%-117K | 51.38%-1.02M | -377.83%-3.61M | -151.49%-622K | -222.00%-804K | 79.74%-79K | -1,082.02%-2.1M | -53.37%1.3M | -83.17%1.21M | 185.14%659K |
| -Change in prepaid assets | 48.45%-1.45M | 162.47%1.13M | -141.02%-914K | 227.13%2.69M | -69.62%1M | -28.97%-2.81M | -745.52%-1.8M | 1,319.11%2.23M | 110.94%822K | -43.61%3.3M |
| -Change in payables and accrued expense | -38.68%-2.71M | -4,111.32%-4.25M | 128.56%5.99M | 66.29%-4.76M | 530.81%12.6M | -173.97%-1.95M | 101.62%106K | -747.74%-20.97M | -336.42%-14.13M | 55.59%-2.92M |
| -Change in other working capital | 2,800.00%108K | 5,300.00%3.74M | -322.00%-111K | -1,300.00%-28K | -800.00%-7K | 95.83%-4K | -148.98%-72K | 115.06%50K | 99.34%-2K | 133.33%1K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 94.47%-135K | 97.69%-211K | 82.21%-5.13M | 231.99%9.37M | 68.12%-2.91M | 72.34%-2.44M | -141.31%-9.15M | -11.01%-28.82M | -13.03%-7.1M | -3.82%-9.12M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -3,380.00%-174K | -280.95%-76K | 96.40%-117K | -278.05%-155K | 101.43%1K | 99.84%-5K | 148.84%42K | -16.75%-3.25M | 98.31%-41K | 77.92%-70K |
| Net business purchase and sale | ---- | ---- | 99.84%-5K | 87.50%-5K | 117.24%5K | ---- | ---- | -560.71%-3.18M | 66.94%-40K | 90.85%-29K |
| Net other investing changes | ---174K | -280.95%-76K | -60.00%-112K | -14,900.00%-150K | 90.24%-4K | --0 | 216.67%42K | 96.96%-70K | 99.96%-1K | ---41K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -3,380.00%-174K | -280.95%-76K | 96.40%-117K | -278.05%-155K | 101.43%1K | 99.84%-5K | 148.84%42K | -16.75%-3.25M | 98.31%-41K | 77.92%-70K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 93.24%-126K | -120.17%-2.73M | 479.80%8.87M | -383.80%-5.4M | 69.82%2.58M | -128.30%-1.87M | 348.11%13.56M | -94.95%1.53M | -109.45%-1.12M | 123.77%1.52M |
| Net issuance payments of debt | 66.46%-212K | -108.71%-370K | 55.07%-2.35M | -2,304.73%-8.86M | 159.83%2.9M | -123.72%-632K | 223.52%4.25M | -39.59%-5.22M | -84.20%402K | 19.36%-4.85M |
| Net common stock issuance | -92.57%86K | --0 | 33.19%15.58M | 354.77%2.56M | -81.73%1.44M | -74.39%1.16M | 3,292.83%10.42M | -70.87%11.69M | -112.74%-1.01M | --7.88M |
| Net other financing activities | --0 | -113.55%-2.36M | 11.82%-4.36M | 274.66%896K | -16.74%-1.76M | -303.72%-2.39M | 52.53%-1.11M | 18.89%-4.94M | -137.42%-513K | -290.91%-1.51M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 93.24%-126K | -120.17%-2.73M | 479.80%8.87M | -383.80%-5.4M | 69.82%2.58M | -128.30%-1.87M | 348.11%13.56M | -94.95%1.53M | -109.45%-1.12M | 123.77%1.52M |
| Net cash flow | ||||||||||
| Beginning cash position | -16.16%19.96M | 18.72%22.99M | -61.20%19.36M | -30.54%19.18M | -44.72%19.5M | -41.29%23.81M | -61.20%19.36M | 3.24%49.9M | -40.99%27.61M | -43.36%35.28M |
| Current changes in cash | 89.91%-435K | -167.87%-3.02M | 111.87%3.63M | 146.12%3.81M | 95.80%-322K | 18.42%-4.31M | 147.65%4.45M | -2,047.77%-30.54M | -365.28%-8.25M | 50.54%-7.66M |
| End cash Position | 0.14%19.53M | -16.16%19.96M | 18.72%22.99M | 18.72%22.99M | -30.54%19.18M | -44.72%19.5M | -41.29%23.81M | -61.20%19.36M | -61.20%19.36M | -40.99%27.61M |
| Free cash flow | 94.47%-135K | 97.69%-211K | 82.21%-5.13M | 231.99%9.37M | 68.12%-2.91M | 72.34%-2.44M | -141.31%-9.15M | -11.01%-28.82M | -13.03%-7.1M | -3.82%-9.12M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg